Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
A selection of articles from the 2020 issue of Paths of Progress.
To see the entire publication, please
download the PDF version. If you'd like to receive a print version of Paths of Progress in the mail, please
complete this form.
Tracing the circuitous path that led to the 2019 Nobel Prize in Physiology or Medicine for Dana-Farber's William Kaelin Jr., MD.
New research shows that CDK 4/6 and PARP Inhibitors can stimulate the immune system to fight cancer, in addition to their known effects in fighting tumor cells.
Understanding how aggressive brain tumors evade treatment with new technology that examines genetic information within individual cells, one at a time.
Machine language technology brings the new capability to study each individual's risks and best treatment options.
Chemical biologists create small molecules to boost discoveries and prototype novel therapies.
Posted on June 18, 2020
Disclosure of Advisory Roles and Certain Industry Support
See an overview of relevant board memberships, outside support, and significant advisory roles as reported by several physicians and researchers featured in the 2020 issue of Dana-Farber's Paths of Progress magazine.
For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to firstname.lastname@example.org.
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.